← Back to Search resultsInvestor profile:
Investor profile:
Novo Holdings

Address:Copenhagen, Hovedstaden, Denmark
Country:
Novo Holdings invests across 7 industries
Most active sector: Biotech (94 deals, ~73% of tracked deals)
Disclosed volume in Biotech: ~8.6B, typical ticket ~91.1M
Also active in: HealthTech, AgriFood, ClimateTech, Industrial
Top 5 sectors shown based on public deals · Full sector breakdown is available in the dashboard for Startup and Professional plans.
Tags:
Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.
Deals total129
As lead investor337Also as a second investor: 7
As a second investor64
May 5, 2026USD 165mLead investor
May 5, 2026
USD 165m
Windward Bio Raises $165M in Crossover Funding
Company site
Lead investor
Windward Bio Raises $165M in Crossover Funding
Company site
April 28, 2026USD 125mLead investor
April 28, 2026
USD 125m
Coultreon Biopharma Raises $125M in Series A Funding
Company site
Lead investor
Coultreon Biopharma Raises $125M in Series A Funding
Company site
April 15, 2026USD 108mLead investor
April 15, 2026
USD 108m
Terremoto Biosciences Raises $108M in Series C Funding
Company site
Lead investor
Terremoto Biosciences Raises $108M in Series C Funding
Company site
March 2, 2026USD 37mSecond investor
March 2, 2026
USD 37m
Alveus Therapeutics Raises $37M in Series A Extension Funding
Company site
Second investor
Alveus Therapeutics Raises $37M in Series A Extension Funding
Company site
November 18, 2025
November 18, 2025